Healthcare Facilities company Aster DM Healthcare announced Q3FY25 results Revenue grew 11% YoY to Rs 1,050 crore in Q3FY25 vs Rs 949 crore in Q3FY24. Operating EBITDA grew 20% YoY to Rs 202 crore in Q3FY25 vs Rs 168 crore in Q3FY24. Operating EBITDA Margins stood at 19.3% in Q3FY25 vs 17.7% in Q3FY24. The Board of directors at its meeting held on 31st January 2025 approved an interim dividend of Rs 4 per equity share Azad Moopen, Founder and Chairman, Aster DM Healthcare, said: “We are pleased with the momentum built in the third quarter of FY25, which reflects our unwavering focus on operational excellence and capacity enhancement. For 9MFY25, our India business achieved 15% YoY growth, reaching Rs 3,138 crore, driven by increased patient volumes and growth in ARPOB. The Operating EBITDA grew by 35% YoY to Rs 613 crore and adjusted net profits (post NCI and excluding merger transaction cost) grew by 65% YoY to Rs 251 crore for 9M FY25. A consistent growth across our core businesses, combined with strategic cost optimization, has significantly strengthened our margins with 9MFY25 Operating EBITDA margins standing at 19.5%.” “As we expand, with plans to surpass ~6,800 beds by FY27, Aster DM Healthcare is well-positioned to meet the increasing demand for advanced healthcare in India. I am happy to announce that Aster DM Healthcare was recently honoured at the ASSOCHAM Healthcare Awards 2024, winning the title of "Best Multispecialty Hospital- Group" while Aster DM Foundation secured a 1st runner up for "Best CSR Excellence in Healthcare”. Result PDF